跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dobumak - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dobumak
Approved
STANDARD
Dobumak
Makcur Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
65c2be4e67063279
Company
Makcur Laboratories Limited
Type
Standard
Approval Details
Approval Id
65c2be4e67063279
Drug Approval Philippines Name
Dobumak
Product Name
Dobumak
Registration Number
DRP-11965
Brand Name
Dobumak
Generic Name
Dobutamine (as hydrochloride)
Dosage Form
Solution for Injection (IV)
Dosage Strength
50 mg/mL
Manufacturer
Makcur Laboratories Limited
Importer
Hillcross Prime, Inc.
Distributor
Hillcross Prime, Inc.
Issuance Date
24 May 2022
Expiry Date
24 May 2027
Pharmacologic Category
Adrenergic and Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
65c2be4e67063279
Type
Standard
Back to Philippines FDA Approvals